FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
31 01 2019
Historique:
received: 16 05 2018
accepted: 01 01 2019
revised: 05 12 2018
entrez: 2 2 2019
pubmed: 2 2 2019
medline: 14 6 2019
Statut: epublish

Résumé

C9ORF72 mutations are the most common cause of familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). MRI studies have investigated structural changes in C9ORF72-associated FTLD (C9FTLD) and provided first insights about a prominent involvement of the thalamus and the cerebellum. Our multicenter,

Identifiants

pubmed: 30705258
doi: 10.1038/s41398-019-0381-1
pii: 10.1038/s41398-019-0381-1
pmc: PMC6355852
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54

Investigateurs

Nibal Ackl (N)
Christine V Arnim (CV)
Joachim Brumberg (J)
Florian Gärtner (F)
Holger Jahn (H)
Elisabeth Kasper (E)
Jan Kassubek (J)
Catharina Prix (C)
Lina Riedl (L)
Carola Roßmeier (C)
Sonja Schönecker (S)
Elisa Semler (E)
Stefan Teipel (S)
Christine Westerteicher (C)
Elisabeth Wlasich (E)

Références

Am J Neurodegener Dis. 2014 Mar 28;3(1):1-18
pubmed: 24753999
Brain. 2008 Dec;131(Pt 12):3277-85
pubmed: 19022861
Brain. 2016 Dec;139(Pt 12):3202-3216
pubmed: 27797809
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):497-505
pubmed: 26473392
Acta Neuropathol. 2014 Mar;127(3):423-439
pubmed: 24407427
Neuroimage Clin. 2016 Dec 02;13:439-445
pubmed: 28116236
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
J Neurochem. 2016 Aug;138 Suppl 1:6-31
pubmed: 27144467
Acta Neuropathol Commun. 2017 Sep 6;5(1):68
pubmed: 28877758
Neurology. 1993 Dec;43(12):2457-65
pubmed: 8255439
J Med Genet. 2014 Jun;51(6):419-24
pubmed: 24706941
Alzheimers Res Ther. 2012 Sep 24;4(5):41
pubmed: 23006986
Indian J Psychiatry. 2010 Jul;52(3):229-35
pubmed: 21180407
Neuron. 2011 Oct 20;72(2):257-68
pubmed: 21944779
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Brain. 2014 Nov;137(Pt 11):3047-60
pubmed: 25273996
Nervenarzt. 2011 Aug;82(8):1002-5
pubmed: 21805118
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neuropathol Appl Neurobiol. 2016 Apr;42(3):242-54
pubmed: 26538301
Neuropathol Appl Neurobiol. 2015 Aug;41(5):601-12
pubmed: 25185840
Neuroimage Clin. 2016 Feb 21;11:287-290
pubmed: 26977398
Curr Opin Neurobiol. 2016 Feb;36:99-106
pubmed: 26555807
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9985-90
pubmed: 8790444
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Neurobiol Aging. 2018 Feb;62:191-196
pubmed: 29172163
Neuroimage Clin. 2016 Oct 22;12:1035-1043
pubmed: 27995069
Neurology. 2013 Oct 8;81(15):1322-31
pubmed: 24005336
J Alzheimers Dis. 2017;58(3):701-709
pubmed: 28482638
Neuroimage. 2003 Jul;19(3):601-12
pubmed: 12880791
Acta Neuropathol Commun. 2014 Jun 20;2:70
pubmed: 24950788
JAMA Neurol. 2018 Feb 1;75(2):236-245
pubmed: 29197216
Lancet Neurol. 2015 Mar;14(3):253-62
pubmed: 25662776
J Neurochem. 2016 Aug;138 Suppl 1:54-70
pubmed: 27306735
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Eur J Nucl Med Mol Imaging. 2014 May;41(5):844-52
pubmed: 24445987
Lancet Neurol. 2015 Mar;14(3):291-301
pubmed: 25638642
Brain. 2012 Mar;135(Pt 3):723-35
pubmed: 22300876

Auteurs

Janine Diehl-Schmid (J)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. janine.diehl-schmid@tum.de.

Abigail Licata (A)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Oliver Goldhardt (O)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Hans Förstl (H)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Igor Yakushew (I)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Markus Otto (M)

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Sarah Anderl-Straub (S)

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Ambros Beer (A)

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Albert Christian Ludolph (AC)

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Georg Bernhard Landwehrmeyer (GB)

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Johannes Levin (J)

Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Munich, Munich, Germany.

Adrian Danek (A)

Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany.

Klaus Fliessbach (K)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Bonn, Bonn, Germany.

Annika Spottke (A)

German Center for Neurodegenerative Diseases (DZNE), Site Bonn, Bonn, Germany.
Department of Neurology, University of Bonn, Bonn, Germany.

Klaus Fassbender (K)

Department of Neurology, Saarland University, Homburg/Saar, Germany.

Epameinondas Lyros (E)

Department of Neurology, Saarland University, Homburg/Saar, Germany.

Johannes Prudlo (J)

Department of Neurology, Rostock University Medical Center, Rostock, Germany.

Bernd Joachim Krause (BJ)

Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.

Alexander Volk (A)

Institute of Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Dieter Edbauer (D)

German Center for Neurodegenerative Diseases (DZNE), Site Munich, Munich, Germany.
Munich Cluster for System Neurology (SyNergy), Munich, Germany.

Matthias Leopold Schroeter (ML)

Clinic for Cognitive Neurology, University Clinic Leipzig, Leipzig, Germany.
Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Alexander Drzezga (A)

Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Cologne, Cologne, Germany.

Johannes Kornhuber (J)

Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

Martin Lauer (M)

Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.

Timo Grimmer (T)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH